V Paul Doria-Rose
Affiliation: National Institutes of Health
- Approaches for classifying the indications for colonoscopy using detailed clinical dataHirut Fassil
Department of Family Medicine and Community Health, and the Center for Clinical Epidemiology and Biostatistics at the Perelman School of Medicine, University of Pennsylvania, 222 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
BMC Cancer 14:95. 2014..The objective of this study was to evaluate the effects of data-source and adjudication on indication classification and on estimates of the effectiveness of screening colonoscopy on late-stage colorectal cancer diagnosis risk...
- Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview SurveyV Paul Doria-Rose
Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892, USA
Cancer Epidemiol Biomarkers Prev 21:1049-59. 2012..The National Lung Screening Trial (NLST), which showed a 20% reduction in lung cancer mortality among those randomized to receive low-dose computed tomography (LDCT), will likely lead to increased screening use...
- Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung ProjectV Paul Doria-Rose
Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 7354, USA
Lung Cancer 63:295-300. 2009..In these data, death certificates were sufficiently sensitive and specific such that their use did not result in a meaningful change to mortality-based outcomes...
- Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung StudyV Paul Doria-Rose
Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Cancer 115:5007-17. 2009..However, these findings were based on incomplete follow-up, and each trial on its own was underpowered to detect a modest mortality benefit...
- Does the source of death information affect cancer screening efficacy results? A study of the use of mortality review versus death certificates in four randomized trialsV Paul Doria-Rose
Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 8574, USA
Clin Trials 7:69-77. 2010..Often in randomized controlled trials of cancer screening, cause of death is determined by a mortality review committee. However, little is known regarding how findings from mortality review compare to those from death certificates alone...
- The yield of surveillance colonoscopy by adenoma history and time to examinationPaul F Pinsky
Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, USA
Clin Gastroenterol Hepatol 7:86-92. 2009..Surveillance colonoscopy is recommended for subjects with a history of adenomas but there is limited information on the yield of surveillance...
- Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopyAdeyinka O Laiyemo
Division of Gastroenterology, Department of Medicine, Howard University College of Medicine, Washington, DC 20060, USA
Cancer Epidemiol 36:395-9. 2012....